The effects of iloprost and beta3 receptor agonist on TRPA1 and TRPC1 immunreactivity in an experimental lower extremty ischemia-reperfusion injury model

BACKGROUND/AIM: In this study, we aimed to investigate the effects of antioxidant iloprost (ILO) and ß3 adrenergic receptor agonist (BRL) on transient receptor potential ankyrin 1 (TRPA1) and transient receptor potential canonical 1 (TRPC1) ion channels on an experimental ischemia and reperfusion in...

Descripción completa

Detalles Bibliográficos
Autores principales: ÜSTÜNEL, Latif, ÖZGÜLER, İbrahim Murat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742476/
https://www.ncbi.nlm.nih.gov/pubmed/34174803
http://dx.doi.org/10.3906/sag-2104-68

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742476/
https://www.ncbi.nlm.nih.gov/pubmed/34174803
http://dx.doi.org/10.3906/sag-2104-68

Ejemplares similares